help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierce, R. H.
Right arrow Articles by Fausto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierce, R. H.
Right arrow Articles by Fausto, N.
(American Journal of Pathology. 2002;160:1555-1560.)
© 2002 American Society for Investigative Pathology

Short Communication

Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci

Robert H. Pierce*, Mary E. Vail{dagger}, Leah Ralph*, Jean S. Campbell* and Nelson Fausto*

From the Department of Pathology*and the Molecular and Cellular Biology Program,{dagger}University of Washington, Seattle, Washington

Tumor development is thought to require both increased proliferation and inhibition of apoptosis. However, the relationship between cell replication and cell death in liver tumorigenesis is complex because both proliferation and apoptosis increase during hepatocarcinogenesis. To investigate the effect of the anti-apoptotic gene Bcl-2 in liver carcinogenesis, we established a line of double transgenic mice that express transforming growth factor-{alpha} (TGF-{alpha}), a liver mitogen, and Bcl-2. Double transgenic mice, TGF-{alpha} and Bcl-2 single transgenics, and wild type received an injection of diethylnitrosamine at 15 days of age. This alkylating agent induces liver carcinogenesis and its effect is greatly enhanced by TGF-{alpha}. We report that Bcl-2 expression inhibited diethylnitrosamine-induced liver carcinogenesis and counteracted the enhancing effect of TGF-{alpha}. Bcl-2 delayed the growth of proliferative foci at the early stages of carcinogenesis and inhibited cell proliferation in these foci. The effect of Bcl-2 on liver carcinogenesis is consistent with its reported ability to interfere with cell replication. The data demonstrate that the expression of an anti-apoptotic gene during liver carcinogenesis causes a delay rather than an increase in tumorigenesis.




This article has been cited by other articles:


Home page
 JEMHome page
K. J. Riehle, J. S. Campbell, R. S. McMahan, M. M. Johnson, R. P. Beyer, T. K. Bammler, and N. Fausto
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
J. Exp. Med., January 21, 2008; 205(1): 91 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. K. Polakos, J. C. Cornejo, D. A. Murray, K. O. Wright, J. J. Treanor, I. N. Crispe, D. J. Topham, and R. H. Pierce
Kupffer Cell-Dependent Hepatitis Occurs during Influenza Infection
Am. J. Pathol., April 1, 2006; 168(4): 1169 - 1178.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Bai, H.-M. Ni, X. Chen, D. DiFrancesca, and X.-M. Yin
Deletion of Bid Impedes Cell Proliferation and Hepatic Carcinogenesis
Am. J. Pathol., May 1, 2005; 166(5): 1523 - 1532.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.